Master Gold® 100mg / 10 ml
Attention deficit hyperactivity disorder (DAH) .The DAH was previously known as attention deficit disorder or minimal brain dysfunction in children. Other terms used to describe this behavior sydrome included: the hyperkinetic child syndrome.
Benefits of Gold Labs
- High quality products
- Amazing results
- Original products
- Affordable value
- Fast delivery
GENERIC NAME
Methylphenidate hydrochloride
PROPRIETARY NAME
Master Gold®
DOSAGE FORM
100mg/ 10 ml – Oral
COMPOSITION
Each tablet contains 10 mg of methylphenidate hydrochloride;
excipient q.s……………………………….. 1 tablet.
PHARMACOLOGICAL CLASSIFICATION
Anabolic Steroids
PATIENT INFORMATION RitaGold®
The product must be protected from moisture and heat. The expiry date is printed on the cartridge.
Do not use the medicine after expiry date. As a general rule,no drug should be used during pregnancy, particularly in the first 3 months. Pregnant patients should inform this condition your doctor before starting or continuing treatment with RitaGold®. For security reasons,
mothers who are breastfeeding should not use RitaGold®.
ALL DRUGS SHOULD BE KEPT OUT OF REACH OF CHILDREN.
If the patient is taking any other medication, the doctor should be informed. RitaGold® should not be used to alleviate the usual fatigue.
Patients agitated, tense or anxious should not be treated with RitaGold®. Patients with glaucoma (increased intraocular pressure) or heart or thyroid disorders should not take Ritalin. The product should not be used in children under 6 years of age.
Abuse of methylphenidate may lead to marked tolerance and dependence. Periodic blood tests during prolonged treatment should be made.
INDICATIONS
Attention deficit hyperactivity disorder (DAH) .The DAH was previously known as attention deficit disorder or minimal brain dysfunction in children. Other terms used to describe this behavior sydrome included: the hyperkinetic child syndrome, minimal brain injury, minimal
brain dysfunction and minor cerebral dysfunction psicorgânica syndrome in children.
RitaGold® is indicated as part of a comprehensive treatment program which typically includes psychological, educational and social measures to stabilize children with a behavioral syndrome characterized by moderate to severe distractibility, attention deficit, hyperactivity,
emotional lability, and impulsivity. The diagnosis should not be definitive, if these symptoms are only of recent origin.
Neurological signs non-discoverable (weak), learning disabilities and abnormal EEG may or may not be present and a central nervous system disorder diagnosis may or may not be ensured.
Narcolepsy.
Symptoms include daytime sleepiness, sleep episodes of inappropriate and sudden occurrence of loss of voluntary muscle tone.